Cargando…
Severe immune thrombocytopenic purpura in critical COVID-19
COVID-19 is a new disease with many undescribed clinical manifestations. We report herein a case of severe immune thrombocytopenic purpura (ITP) in a critical COVID-19 patient. A patient presented a severe episode of immune thrombocytopenia (< 10 × 10(9)/L) 20 days after admission for a critical...
Autores principales: | Lévesque, Valérie, Millaire, Émilie, Corsilli, Daniel, Rioux-Massé, Benjamin, Carrier, François-Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327458/ https://www.ncbi.nlm.nih.gov/pubmed/32613314 http://dx.doi.org/10.1007/s12185-020-02931-9 |
Ejemplares similares
-
Thrombotic thrombocytopenic purpura as the initial presentation of COVID‐19
por: Beaulieu, Marie‐Claude, et al.
Publicado: (2021) -
Immune Thrombocytopenic Purpura in Patients with COVID-19
por: Revuz, Sabine, et al.
Publicado: (2020) -
Treatment of Severe Immune Thrombocytopenic Purpura Associated with COVID-19
por: Ahmed, Nayab, et al.
Publicado: (2021) -
COVID-19 Vaccination Associated Severe Immune Thrombocytopenic Purpura
por: Sharawi, Said, et al.
Publicado: (2022) -
Immune thrombocytopenic purpura
por: Zainal, Abir, et al.
Publicado: (2019)